Company intelligence / Profile preview

Chongqing Ximeien Pharmaceutical

Chongqing, Chongqing, Chinaximeien.com ↗
Ownership
Private
Development stage
Other
01

Overview

Chongqing Ximeien Pharmaceutical is a China-based biopharmaceutical company specializing in the research, development, and commercialization of high-end generic drugs and innovative biologics. The company maintains a strong focus on ophthalmology and oncology, with a pipeline featuring several biosimilar candidates targeting vascular endothelial growth factor (VEGF). Its lead programs include biosimilars for ranibizumab and bevacizumab, aimed at treating retinal diseases and various cancers. Ximeien operates integrated R&D and manufacturing facilities in Chongqing to support its goal of providing affordable, high-quality therapeutic solutions. The company is recognized as a key high-tech enterprise within the Chongqing region, contributing to the local biotechnology ecosystem.

Therapeutic areas
OncologyOphthalmology
Modalities
Monoclonal antibodyBiologicMonoclonal antibody fragmentRecombinant fusion proteinSmall molecule
Industry
Biotech
02

Drug pipeline

1 asset

Ximeien Salicylic Acid Oil-Control Anti-Dandruff Shampoo

4

Beyond the preview

Go deeper on Chongqing Ximeien Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chongqing Ximeien Pharmaceutical.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call